Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

SINOVAC BIOTECH LTD.

(SVA)
  Report
Delayed Nasdaq  -  04:00 2019-02-22 pm EST
6.470 USD   -0.31%
11/04Sinovac Biotech Says World Health Organization Approved Varicella Vaccine
MT
11/03SINOVAC Varicella Vaccine Prequalified by WHO
BU
11/03Sinovac Varicella Vaccine Prequalified by WHO
CI
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Indonesia approves first home-grown COVID vaccine for emergency use - media

09/28/2022 | 10:37pm EST

JAKARTA, Sept 28 (Reuters) - Indonesia has approved its first domestically-produced COVID-19 vaccine for emergency use for people over 18, the chief of the country's food and drugs agency (BPOM) was quoted by news media as saying on Wednesday.

The Indovac vaccine has been developed by Indonesia's state-owned pharmaceutical company Bio Farma and the Texas Children’s Hospital Center for Vaccine Development at Baylor College of Medicine.

Penny Lukito, the head of BPOM, was cited by news portal CNN Indonesia as saying the approval was "given as a primary vaccine for adults."

Penny and a Bio Farma spokesperson did not immediately respond to requests for comment.

Bio Farma said this month it would produce 20 million doses of the vaccine in 2022 and 100 million doses by 2024. It has also said it has sought a halal certificate - which would make the vaccine permissible under Islam - from relevant authorities.

Indonesia is the world's biggest Muslim-majority nation.

Bio Farma chief Honesti Basyir said earlier this month that the vaccines were intended to "help reduce the nation's dependency on imported vaccines," adding 80% of Indovac is locally-sourced.

Indonesia, which reported one of the highest transmission rates of COVID-19 in the world last year, has used vaccines produced by China's Sinovac Biotech, Pfizer Inc and BioNTech as well as Moderna Inc.

Bio Farma has said it has also sought an emergency use approval from the World Health Organization (WHO).

Indonesia is also developing another home-grown vaccine called Inavac. (Reporting by Stanley Widianto; Editing by Raju Gopalakrishnan)


ę Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
BIONTECH SE 0.16% 169.74 Delayed Quote.-34.16%
MODERNA, INC. 0.48% 182.35 Delayed Quote.-28.20%
PFIZER, INC. -0.33% 50.91 Delayed Quote.-13.50%
SINOVAC BIOTECH LTD. -0.31% 6.47 Delayed Quote.0.00%
All news about SINOVAC BIOTECH LTD.
11/04Sinovac Biotech Says World Health Organization Approved Varicella Vaccine
MT
11/03SINOVAC Varicella Vaccine Prequalified by WHO
BU
11/03Sinovac Varicella Vaccine Prequalified by WHO
CI
10/31SINOVAC to Showcase Products at CPHI Frankfurt
AQ
10/28SINOVAC to Showcase Products at CPHI Frankfurt
BU
09/28Indonesia approves first home-grown COVID vaccine for emergency use - media
RE
09/06Sinovac Biotech Gets Chilean Health Regulator Approval to Start Clinical Trial for Its ..
MT
09/06SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine..
BU
09/06Sinovac Biotech Ltd. Announces the Chilean Public Health Institute Approve Phase II Cli..
CI
08/03SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong Kon..
BU
More news
Financials ()
Sales 2021 19 375 M - -
Net income 2021 8 467 M - -
Net cash 2021 13 270 M - -
P/E ratio 2021 0,09x
Yield 2021 -
Capitalization 642 M 642 M -
EV / Sales 2020 -0,78x
EV / Sales 2021 -0,65x
Nbr of Employees 4 281
Free-Float 67,4%
Chart SINOVAC BIOTECH LTD.
Duration : Period :
Sinovac Biotech Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Wei Dong Yin Chairman, President, CEO, Secretary & MD
Nan Wang CFO & Vice President-Business Development
Qiang Gao Chief Operating Officer & Vice President
Yuk Lam Lo Independent Director
Jian Li Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SINOVAC BIOTECH LTD.0.00%642
CSL LIMITED3.84%98 736
SAMSUNG BIOLOGICS CO.,LTD.-3.65%47 474
BIOGEN INC.24.58%43 042
WUXI BIOLOGICS (CAYMAN) INC.-44.03%28 080
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-28.50%20 307